The causative species of cutaneous leishmaniasis determines the clinical features and
courses, and treatments. Intralesional or systemic antimonials are the gold standard for the …

Leishmaniasis, usually caused by the genus Leishmania, has not received the attention it
deserves and in recent times has developed into a major health problem worldwide. 1, 2 …

Leishmaniasis remains a public health problem worldwide, affecting approximately 12
million people in 88 countries; 50 000 die of it each year. The disease is caused by …

We report herein the synthesis and biological activities (cytotoxicity, leishmanicidal and
trypanocidal) of six quinoline-chalcone and five quinoline-chromone hybrids. The …

An original series of 4-substituted pyrrolo [1, 2-a] quinoxaline derivatives, new structural
analogues of Galipea species quinoline alkaloids, was synthesized from various substituted …

Epidemics of fatal visceral leishmaniasis caused by the intracellular protozoan Leishmania
are a severe public health problem in tropical and subtropical regions of the world. One …

Nitroaromatic antibiotics show activity against anaerobic bacteria and parasites, finding use
in the treatment of Heliobacter pylori infections, tuberculosis, trichomoniasis, human African …

A highly efficient synthesis of trans-alkenylazaarene under catalyst-free conditions was
developed via the addition of methylazaarenes to N-sulfonyl aldimines and a subsequent C …

Recent years have seen a significant improvement in available treatment options for
leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the …

Leishmaniasis, a group of tropical diseases caused by protozoan parasites of genus
Leishmania, is a major health problem worldwide that affects millions of people especially in …